Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer
Emilie A. K. Warren,Jacklyn N. Hammons, Jessica M. Keilson,Guillermo O. Rangel Rivera,Megan M. Wyatt, Caroline R. Goel,Curtis J. Henry, Sarah Kulkarni, Yuan Li,Brian Robinson,Alyssa M. Krasinskas,Nilofer S. Azad,Mark Yarchoan,Shishir K. Maithel,Chrystal M. Paulos, Gregory B. Lesinski ANNALS OF SURGICAL ONCOLOGY（2024）
AI 理解论文
溯源树
样例
